Levi & korsinsky reminds regeneron pharmaceuticals, inc. investors of the pending class action lawsuit with a lead plaintiff deadline of march 10, 2025 - regn

New york, ny / access newswire / january 31, 2025 / if you suffered a loss on your regeneron pharmaceuticals, inc. (nasdaq:regn) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=126333&wire=1 or contact joseph e. levi, esq.
REGN Ratings Summary
REGN Quant Ranking